HIFU Focal Ablation for PCa Offers Adequate Short-Term Cancer Control
In a study, men who underwent high-intensity focused ultrasound partial gland ablation for prostate cancer had excellent preservation of potency and continence.
Prostate Cancer News
PROSTATE CANCER ADVISOR
Prostate Cancer News
Prostate Cancer Metastasizes by Hijacking a Developmental Epigenetic Program
Localized prostate cancer is thought to metastasize by tapping into a developmental program used by its embryonic ancestors.
Darolutamide Prolongs Overall Survival in nmCRPC
Darolutamide also improved secondary endpoints, including the time to pain progression, cytotoxic chemotherapy, and first symptomatic skeletal event.
Oral Antiandrogens Found to Increase Dementia Risk
In a study, only androgen deprivation therapy with oral antiandrogens were associated with an increased risk for dementia and Alzheimer disease.
Doubling of Radical Surgery Rates for High-Risk Prostate Cancer Reported
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
Prostate Cancer Surgery Delay Not Linked to Worse Oncologic Outcomes
Deferring radical prostatectomy for intermediate- and high-risk prostate cancer for several months does not increase the risk for adverse oncologic findings.
FDA Approves Blood-Based Test as Companion Diagnostic for Multiple Cancer Drugs
Using a blood sample, the test is able to analyze more than 300 cancer-associated genes for alterations.
New Tool May Enable Less Intensive Prostate Cancer Active Surveillance
The model, based on routinely collected clinical characteristics, provides information that can enhance discussions between health care professionals and patients on active surveillance intensity.
Prostate Cancer Therapy Options Have Similar Cost-Effectiveness, Study Finds
Given that the findings do not show major differences between care options in prostate cancer, cost probably shouldn’t be a major factor driving decision making.
Metastatic Prostate Cancer at Diagnosis Has a Better Prognosis Than Recurrent Disease
Metastatic prostate cancer (PCa) at diagnosis and recurrent metastatic PCa after initial treatment may be distinct biological entities with different survival trajectories, according to investigators.
Fewer Systematic Biopsy Cores May Not Lower PCa Detection Rate
In a study of patients undergoing transperineal prostate biopsy, the detection rate of clinically significant prostate cancer did not differ significantly between targeted biopsy (TB) with fewer systematic biopsy (SB) cores and TB with SB of the whole prostate.
Mature Data Confirm Enzalutamide Survival Benefit in mCRPC
The latest analyses found 5-year overall survival benefits across low-, intermediate-, and high-risk subgroups of men with chemotherapy-naïve metastatic castration-resistant prostate cancer.
Priorities in Prostate Cancer Care During the Pandemic
The authors of a new review discuss priorities, adjustments, and tailored approaches to prostate cancer management during the COVID-19 pandemic.
Prostate Biopsy Delays Do Not Affect Pathologic Findings
Postponing transperineal prostate biopsies in men with suspicious MRI-detected lesions had no effect on biopsy findings, which could have important implications during the COVID-19 pandemic.
Study Validates 3-Tiered Subclassification of High-Risk Prostate Cancer
The new stratification model may aid treatment decision-making for men with “favorable,” high-risk, or “very” high-risk prostate cancer.
17q22 Loss Associated With Survival in Enzalutamide-Resistant mCRPC
Copy number loss of 17q22 was associated with enzalutamide resistance and shorter overall survival among men with metastatic castration-resistant prostate cancer.
ADT Use Enables Delay in Prostate Cancer Radiation Therapy
Radiation therapy for higher-risk prostate cancer can be delayed for up to 6 months following initiation of hormonal therapy without incurring a greater mortality risk, a finding that has implications for patient care during the COVID-19 pandemic.
The Twitter Effect on How Oncologists Conduct and Share Research
The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.
Radiation Therapy After Prostate Surgery Worsens Sexual, Urinary Function
Allowing an approximately 24-month recovery period after prostate surgery before giving radiation therapy may be optimal for preserving erectile function provided oncologic control is not compromised, according to investigators.
How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
